Picture of DSM-Firmenich AG logo

DSFIR — DSM-Firmenich AG News Story

0.000.00%
nl flag iconLast trade - 00:00
IndustrialsBalancedLarge Cap

Brief: DSM-Firmenich Eyes 2026 Adjusted EBITDA Margin Of Around 20%

March 12 (Reuters) - DSM-Firmenich AG DSFIR.AS:

DSM-FIRMENICH OUTLINES ACTION PLAN AT INVESTOR EVENT TO ACCELERATE PERFORMANCE, FOLLOWING COMPLETION OF TRANSFORMATION

OUTLOOK 2026: OSG: 2-4% ORGANIC SALES GROWTH

OUTLOOK 2026: ADJUSTED EBITDA MARGIN: AROUND 20%

OUTLOOK 2026: CASH CONVERSION ADJUSTED GROSS OPERATING FREE CASH FLOW TO SALES OF 11-12%

DSM-2026 OUTLOOK ASSUMES NO PROLONGED OR SIGNIFICANT IMPACT FROM BROADER GEOPOLITICAL DEVELOPMENTS IN MIDDLE EAST

MID-TERM TARGET FOR ADJUSTED GROSS OPERATING FREE CASH FLOW HAS BEEN INCREASED FROM ≥10% TO ≥14%

WILL START A NEW PROGRAM TO REPURCHASE ORDINARY SHARES FOR A TOTAL AMOUNT OF EUR 540 MILLION

Source text: ID:nGNE75BygS

Further company coverage: DSFIR.AS

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on DSM-Firmenich AG

See all news